<DOC>
	<DOCNO>NCT01472432</DOCNO>
	<brief_summary>A randomized versus placebo trial design evaluate clinical humoral effect 4 month vildagliptin heal chronic ulcer type 2 diabetes .</brief_summary>
	<brief_title>DPP IV Inhibition Facilitates Healing Chronic Foot Ulcers Type 2 Diabetes</brief_title>
	<detailed_description>The chronic foot ulcer lead cause hospital admission people diabetes develop world major morbidity associate diabetes , often lead pain , suffering , poor quality life patient . Chronic diabetic foot ulcer estimate occur 15 % patient diabetes precede 84 % diabetes-related lower-leg amputations.The pathophysiology chronic diabetic ulcer complex still incompletely understood , important predisposing factor diabetic neuropathy vasculopathy . Both micro macroangiopathy strongly contribute development delay heal diabetic wound , impaired tissue feed response ischemia . HIF-1α VEGF , well NO production iNOS , may contribute limitation hypoxic injury promote angiogenesis wound healing . Experimental pathological study suggest suggest incretin hormone glucagon-like peptide-1 ( GLP-1 ) may improve VEGF generation , promote pancreatic islet viability up-regulation HIF1α . Therefore , aim study evaluate effect augmentation GLP-1 , inhibitor dipeptidyl peptidase IV ( DPP-4 ) , vildagliptin , HIF-1α , VEGF iNOS diabetic chronic ulcer .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<criteria>Type 2 diabetes Oral hypoglycemic agent treatment Chronic foot ulcer Adequate blood circulation ( perfusion ) assess dorsum transcutaneous oxygen test &gt; 30 mmHg , anklebrachial index value &gt; 0.7 &lt; 1.2 toe pressure &gt; 30 mmHg , Doppler arterial aveforms triphasic biphasic ankle affect leg Written consensus Active Charcot disease Ulcers result electrical , chemical , radiation burn Collagen vascular disease Ulcer malignancy Untreated osteomyelitis , cellulitis Ulcer treatment normothermic hyperbaric oxygen therapy Concomitant medication corticosteroid , immunosuppressive medication , chemotherapy Recombinant autologous growth factor product Skin dermal substitute within 30 day study start Use enzymatic debridement treatment Pregnant nursing mother</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>heal</keyword>
	<keyword>foot ulcer</keyword>
	<keyword>vildagliptin</keyword>
</DOC>